Skip to main navigation

Global

Japan
USA

Healthcare Professionals
Patients & Care Partners
Partnerships
Contact

About
Back

Transforming the treatment of cancer and other serious diseases

About Genmab
FEATURED

A history of accomplishments rooted in science
Antibody Science
Back

Pioneering technologies that create novel antibody therapeutics to treat cancer and other serious diseases.

Antibody Science Overview
FEATURED

Science that can transform lives
Our Impact
Back

Discover how Genmab makes a positive impact for patients, communities and employees

Our Impact
FEATURED

Incorporating the patient perspective
Investors
Back

Corporate and financial resources for Genmab investors, potential shareholders and analysts

Investor Relations
FEATURED

Genmab at a Glance
News & Insights
Back

Find press releases, articles and access media from Genmab

Latest Updates
FEATURED

Genmab Hosts Plenary and Life Science Fair on AI’s Role in the Future of Healthcare and Labs
Careers

Healthcare Professionals
Patients & Care Partners
Partnerships
Contact

Genmab regional sites

Japan
USA

Event Details

Genmab's Investor Call Regarding HexaBody-CD38

Mar 10, 2025 5:00 PM CET

Listen to the Webcast Replay

Supporting Materials

Investor Call Regarding HexaBody-CD38_March 10, 2025 977.2 KB

Transforming lives with pioneering antibody science

Quick Links

News
Medicines
Pipeline
Stories

Explore

About
Antibody Science
Impact
Investors
News & Insights
Careers

Resources

Healthcare Professionals
Patients & Care Partners

Genmab Websites

Japan Opens in a new tab
USA Opens in a new tab

Get in touch

Contact us

Follow Genmab

Accessibility Policy
Cookie Policy
Your Cookie Preferences
Disclaimer
Privacy Policy
Social Media Terms of Use

©2026 Genmab A/S

You are now leaving Genmab.com to go to our collaborator’s website.

If you continue, we encourage you to read the website’s privacy and cookie policy.

Continue